This article was taken from Pharmafile Summer 2022, page 22. Samedan Ltd
Learn more about Aptar Pharma Expertise
in Pulmonary Drug Delivery
This Might Also Be of Interest

Elevating Medication Adherence and Clinical Outcomes with Connected Drug Delivery
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Advancing Inhaled & Nasal Drug Clinical Studies: Insights & Strategies
Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Leachables Assessment: New pMDI with Low-GWP Propellants
Publications, Pharmaceutical, Product Solutions, Sustainability, Device Innovations, Brand Differentiation, Market Insights

Performance of Low-GWP Propellants in pMDIs: Filling and Dose Evaluation
Publications, Pharmaceutical, Market Insights, Product Solutions, Sustainability, Device Innovations